Two Sigma Securities, LLC Histogen Inc. Transaction History

Two Sigma Securities, LLC

  • $10.3 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$0.71 - $1.22 $1,655 - $2,845
-2,332 Reduced 18.19%
10,491 $7,000
Q1 2023

May 15, 2023
BUY
$0.85 - $1.41 $2,312 - $3,835
2,720 Added 26.92%
12,823 $15,000
Q4 2022

Feb 14, 2023
SELL
$0.79 - $1.35 $646 - $1,104
-818 Reduced 7.49%
10,103 $8,000
Q3 2022

Nov 14, 2022
BUY
$1.38 - $3.76 $15,070 - $41,062
10,921 New
10,921 $15,000

Others Institutions Holding HSTO

# of Institutions
1
Shares Held
17
Call Options Held
0
Put Options Held
0
View Full List

About Histogen Inc.

HSTO Quotes by TradingView
  • Ticker HSTO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,497,450
  • Market Cap $524K
  • Description
  • Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. It offers HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; HST-004, a cell conditioned media...
More about HSTO
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email